After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...
Mar 19, 2018
0
486
Stem-cell scientists led by Dr. John Dick have discovered a completely new view of how human blood is made, upending conventional dogma from the 1960s.
Nov 5, 2015
2
919
Two existing cancer drugs turn on a gene that tells tumor cells to remain inactive, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published today in Nature Communications.
Feb 2, 2015
0
369
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...
Aug 17, 2017
0
852
Scientists fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer recurrence in patients after surgery.
Oct 2, 2018
0
53
Cancer stem cells can be put into "hibernation" by a little-known drug called diphenyleneiodonium (DPI) according to researchers from the University of Salford, UK. DPI effectively switches off the cancer stem cells, preventing ...
Jan 30, 2018
0
53
Shikhar Mehrotra, Ph.D. and Xue-Zhong Yu, M.D., National Institutes of Health-funded researchers at the Medical University of South Carolina (MUSC), have discovered a way to improve immune-based treatments, such as adoptive ...
Jul 8, 2019
0
216
A team headed by Prof. Massimiliano Mazzone (VIB-KU Leuven Center for Cancer Biology), in collaboration with Dr. Emanuele Berardi and Dr. Min Shang, revealed a new metabolic dialogue between inflammatory cells and muscle ...
Oct 29, 2020
0
342
Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment.
Jul 3, 2018
0
147
A new study led by scientists at The Scripps Research Institute (TSRI) suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages.
Nov 11, 2016
0
639
